Eansor Norman David 4
4 · Marker Therapeutics, Inc. · Filed Feb 14, 2025
Insider Transaction Report
Form 4
EANSOR N DAVID
Director
Transactions
- Award
Stock Option (right to buy)
2025-02-12+30,000→ 30,000 totalExercise: $1.59Exp: 2035-02-12→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]Represents options granted under the Company's 2020 Omnibus Stock Ownership Plan. One third of the shares vest on the first anniversary of the grant date and the remainder of the shares subsequently vest in equal annual installments over the second and third anniversary of the grant date subject to the Reporting Person's continued service as a director. The option exercise price is the closing price on the date of the grant, February 12, 2025.